4.6.2014   

EN

Official Journal of the European Union

C 167/1

4.6.2014   

EN

Official Journal of the European Union

C 167/2

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32014M7223. EUR-Lex is the online access to the European law.

4.6.2014   

EN

Official Journal of the European Union

C 167/2

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32014M7210. EUR-Lex is the online access to European law.

4.6.2014   

EN

Official Journal of the European Union

C 167/3

4.6.2014   

EN

Official Journal of the European Union

C 167/4

(1)

Under Article 168(2) of the Treaty on the Functioning of the European Union, Member States are required, in liaison with the Commission, to coordinate among themselves their policies and programmes in the areas referred to in paragraph 1. The Commission may, in close contact with the Member States, take any useful initiative to promote such coordination, in particular initiatives aiming at the establishment of guidelines and indicators, the organisation of exchange of best practice, and the preparation of the necessary elements for periodic monitoring and evaluation.

(2)

The Commission White Paper ‘Together for Health: A strategic approach for the EU 2008-2013’ (1) adopted by the Commission on 23 October 2007, developing the EU health strategy, identified cancer as a priority for action.

(3)

The Council adopted on 2 December 2003 a Recommendation on cancer screening (2).

(4)

The Council adopted on 10 June 2008 Conclusions on ‘Reducing the burden of Cancer’ (3) and on 13 September 2010 on ‘Action against Cancer’ (4).

(5)

The European Commission adopted on 24 June 2009 a ‘Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Action Against Cancer: European Partnership’ (5).

(6)

The Communication from the President to the Commission of 10 November 2010 entitled ‘Framework for Commission Expert Groups: Horizontal rules and public register’ (6) (hereinafter, the ‘the framework for Commission expert groups’) sets out a revised set of rules for all Commission expert groups.

(7)

The preparation and implementation of activities in the field of cancer require close cooperation with the specialized bodies in Member States and with the interested parties. This would respond to demands from Member State representatives and stakeholders for an improved coordination in the light of the expanding cancer work. In addition, sharing knowledge and information can help resolve some of the difficulties that Member States are facing in cancer control and will facilitate cooperation with other significant actors such as patient’s organisations.

(8)

Advice from high-level European experts in the field of cancer should be constantly made available in the form of an expert group established by the Commission. The expert group on cancer control should, at the request of the Commission, provide advice and expertise to the Commission in formulating and implementing the Union’s activities in the field of cancer and foster exchanges of relevant experience, policies and practices between the Member States and the various parties involved.

(9)

This group should be composed of representatives of Member States, representatives of patients’ organisations in the field of cancer, representatives from European associations acting in the field of cancer prevention, European professional associations or scientific societies acting in the field of cancer, a representative of producers of products or service providers in the field of cancer and a representative of the International Agency for Research on Cancer, in order to allow a wide representation of stakeholders and experts in the area of cancer.

(10)

The expert group on cancer control should not act as a committee within the meaning of Regulation (EU) No 182/2011 of the European Parliament and of the Council of 16 February 2011 laying down the rules and general principles concerning mechanisms for control by Member States of the Commission’s exercise of implementing powers (7).

(11)

Personal data should be processed in accordance with Regulation (EC) No 45/2001 of the European Parliament and of the Council of 18 December 2000 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data (8).

(12)

Commission Decision 96/469/EC of 30 July 1996 (9) establishing an advisory committee for cancer prevention should thereby be repealed,

(a)

assist the Commission in the drawing up of legal instruments and policy documents, guidelines and recommendations on cancer control, as well as cancer data including epidemiology, early detection of cancer and cancer screening, information of the public on cancer prevention, quality assurance procedure in cancer management and preventive aspects which may be developed on the basis of the results of fundamental, translational and clinical cancer research carried out under the EU research programmes and other international or national research initiatives, as well as on cross cutting themes related to cancer;

(b)

advise the Commission in the implementation of Union actions and suggest improvements to the measures taken;

(c)

advise the Commission in the monitoring, evaluation and dissemination of the results of measures taken at Union and national level;

(d)

advise the Commission on international cooperation;

(e)

facilitate coordination and exchange of information between Member States;

(f)

provide an overview to the Commission on Union and national policies;

(g)

gathering information of relevant experience, policies and practices of the Member States and the various parties involved.

(a)

Member States’ competent authorities;

(b)

three representatives of patients’ organisations in the field of cancer;

(c)

two representatives of European associations acting in the field of cancer prevention;

(d)

three representatives of European professional associations or scientific societies acting in the field of cancer;

(e)

one representative of producers of products or service providers in the field of cancer;

(f)

one representative of the International Agency for Research on Cancer.

(a)

permanent incapacity to attend the meetings;

(b)

incapacity to contribute effectively to the group’s deliberations;

(c)

non-compliance with the conditions set out in Article 339 of the Treaty on the Functioning of the European Union;

(d)

subsequent non-compliance with the qualifications and conditions specified in the call for expression of interests as referred to in paragraph 5.

4.6.2014   

EN

Official Journal of the European Union

C 167/9

(1)

Abbeville

(2)

Agen-La Garenne

(3)

Ajaccio-Campo dell'Oro

(4)

Albert-Bray

(5)

Amiens-Glisy

(6)

Angers-Marcé

(7)

Angoulême-Brie-Champniers

(8)

Annecy-Methet

(9)

Annemasse

(10)

Auxerre-Branches

(11)

Avignon-Caumont

(12)

Bâle-Mulhouse

(13)

Bastia-Poretta

(14)

Beauvais-Tillé

(15)

Bergerac-Roumanière

(16)

Besançon-La Vèze

(17)

Béziers-Vias

(18)

Biarritz-Bayonne-Anglet

(19)

Bordeaux-Mérignac

(20)

Brest-Guipavas

(21)

Brive-Souillac

(22)

Caen-Carpiquet

(23)

Calais-Dunkerque

(24)

Calvi-Sainte-Catherine

(25)

Cannes-Mandelieu

(26)

Carcassonne-Salvaza

(27)

Châlons-Vatry

(28)

Chambéry-Aix-les-Bains

(29)

Châteauroux-Déols

(30)

Cherbourg-Maupertus

(31)

Clermont-Ferrand-Aulnat

(32)

Colmar-Houssen

(33)

Deauville-Saint-Gatien

(34)

Dijon-Longvic

(35)

Dinard-Pleurtuit

(36)

Dole-Tavaux

(37)

Épinal-Mirecourt

(38)

Figari-Sud Corse

(39)

Grenoble-Saint-Geoirs

(40)

Hyères-Le Palyvestre

(41)

Issy-les-Moulineaux

(42)

La Môle

(43)

Lannion

(44)

La Rochelle-Laleu

(45)

Laval-Entrammes

(46)

Le Castelet

(47)

Le Havre-Octeville

(48)

Le Mans-Arnage

(49)

Le Touquet-Paris-Plage

(50)

Lille-Lesquin

(51)

Limoges-Bellegarde

(52)

Lognes-Emerainville

(53)

Lorient-Lann-Bihoué

(54)

Lyon-Bron

(55)

Lyon-Saint-Exupéry

(56)

Marseille-Provence

(57)

Metz-Nancy-Lorraine

(58)

Monaco-Héliport

(59)

Montbéliard-Courcelles

(60)

Montpellier-Méditerranée

(61)

Nantes-Atlantique

(62)

Nevers-Fourchambault

(63)

Nice-Côte d'Azur

(64)

Nîmes-Garons

(65)

Orléans-Bricy

(66)

Orléans-Saint-Denis-de-l'Hôtel

(67)

Paris-Charles de Gaulle

(68)

Paris-Le Bourget

(69)

Paris-Orly

(70)

Pau-Pyrénées

(71)

Perpignan-Rivesaltes

(72)

Poitiers-Biard

(73)

Quimper-Cornouaille, on a temporary basis from 22 May to 7 September 2014.

(74)

Rennes Saint-Jacques

(75)

Rodez-Marcillac

(76)

Rouen-Vallée de Seine

(77)

Saint-Brieuc-Armor

(78)

Saint-Étienne-Bouthéon

(79)

Saint-Nazaire-Montoir

(80)

Strasbourg-Entzheim

(81)

Tarbes-Ossun-Lourdes

(82)

Toulouse-Blagnac

(83)

Tours-Saint-Symphorien

(84)

Troyes-Barberey

(85)

Vichy-Charmeil

(1)

Ajaccio

(2)

Bastia

(3)

Bayonne

(4)

Bonifacio

(5)

Bordeaux

(6)

Boulogne

(7)

Brest

(8)

Caen-Ouistreham

(9)

Calais

(10)

Calvi

(11)

Cannes-Vieux Port

(12)

Carteret

(13)

Cherbourg

(14)

Dieppe

(15)

Douvres

(16)

Dunkerque

(17)

Granville

(18)

Honfleur

(19)

La Rochelle-La Pallice

(20)

Le Havre

(21)

Les Sables-d'Olonne-Port

(22)

L'Ile-Rousse

(23)

Lorient

(24)

Marseille

(25)

Monaco-Port de la Condamine

(26)

Nantes-Saint-Nazaire

(27)

Nice

(28)

Port-de-Bouc-Fos/Port-Saint-Louis

(29)

Port-la-Nouvelle

(30)

Porto-Vecchio

(31)

Port-Vendres

(32)

Roscoff

(33)

Rouen

(34)

Saint-Brieuc (maritime)

(35)

Saint-Malo

(36)

Sète

(37)

Toulon

(1)

Gare d’Ashford International

(2)

Gare d'Avignon-Centre

(3)

Cheriton/Coquelles

(4)

Gare de Chessy-Marne-la-Vallée

(5)

Gare de Fréthun

(6)

Gare de Lille-Europe

(7)

Gare de Paris-Nord

(8)

Gare de St-Pancras International

(9)

Gare d'Ebbsfleet International

(1)

Pas de la Case-Porta

4.6.2014   

EN

Official Journal of the European Union

C 167/14

4.6.2014   

EN

Official Journal of the European Union

C 167/15

1.

On 26 May 2014 the European Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Ageas Insurance International NV (‘Ageas’, the Netherlands), a company belonging to the international group Ageas SA, acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of Companhia Portuguesa de Seguros SA (‘Ocidental Seguros’, Portugal) and of Companhia Portuguesa de Seguros de Saúde SA (‘Médis’, Portugal) by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for Ageas: provision of life and non-life insurance services to personal, business and institutional customers,

—   for Médis and Ocidental Seguros: provision of non-life insurance services.

3.

On preliminary examination, the European Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The European Commission invites interested third parties to submit their possible observations on the proposed operation to the European Commission.

Observations must reach the European Commission not later than 10 days following the date of this publication. Observations can be sent to the European Commission by fax (+32 22964301), by e-mail to [email protected] or by post, under reference number M.7262 — Ageas/Ocidental Seguros/Médis to the following address:

4.6.2014   

EN

Official Journal of the European Union

C 167/16

1.

On 26 May 2014, the European Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which funds managed by affiliates of the Carlyle Group L.P (‘Carlyle’, United States) acquires indirectly through a special purpose acquisition vehicle within the meaning of Article 3(1)(b) of the EU Merger Regulation sole control over T-I Holdings S.à.R.L. (‘T-I Holdings’, Luxembourg), which wholly owns Traxys S.à.R.L. (‘Traxys’, United States), by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for Carlyle: the global alternative asset management. Carlyle manages funds that invest globally across different investment disciplines (corporate private equity, real assets, global market strategies and solutions),

—   for Traxys: the commodities trade focused primarily on the sourcing and sale of metals, materials for steel mills and foundries and industrial minerals (‘raw materials’) and on the provision of ancillary services.

3.

On preliminary examination, the European Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The European Commission invites interested third parties to submit their possible observations on the proposed operation to the European Commission.

Observations must reach the European Commission not later than 10 days following the date of this publication. Observations can be sent to the European Commission by fax (+32 22964301), by e-mail to [email protected] or by post, under reference number M.7226 — Carlyle/Traxys, to the following address:

4.6.2014   

EN

Official Journal of the European Union

C 167/17

1.

On 27 May 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the state-owned enterprise China Huaxin Post and Telecommunication Economy Development Center (‘China Huaxin’), China, acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the enterprise solutions business of Alcatel-Lucent (‘ALE’), France, by way of a purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for China Huaxin: investments in the information and communication technology sectors; and

—   for ALE: providing hardware and software for enterprise communications and network solutions.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to [email protected] or by post, under reference number M.7244 — China Huaxin Post and Telecommunication Economy Development Center / Alcatel-Lucent Enterprise Business, to the following address: